USD 0.16
(0.65%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.35 USD | 14.63% |
2022 | -0.41 USD | -2.5% |
2021 | -0.40 USD | 0.0% |
2020 | -0.40 USD | -150.0% |
2019 | -0.16 USD | -1211.48% |
2018 | -0.01 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.07 USD | -7.14% |
2024 Q2 | -1.89 USD | -2700.0% |
2023 Q2 | -0.09 USD | -21.83% |
2023 Q1 | -0.08 USD | -126.98% |
2023 FY | - USD | 14.63% |
2023 Q3 | -0.09 USD | 4.88% |
2023 Q4 | -0.06 USD | 29.77% |
2022 Q4 | -0.03 USD | 69.0% |
2022 Q3 | -0.11 USD | 26.67% |
2022 Q2 | -0.15 USD | -122.55% |
2022 Q1 | -0.07 USD | 43.83% |
2022 FY | - USD | -2.5% |
2021 Q4 | -0.12 USD | -9.09% |
2021 FY | - USD | 0.0% |
2021 Q1 | -0.12 USD | -96.72% |
2021 Q3 | -0.11 USD | -16.03% |
2021 Q2 | -0.09 USD | 21.0% |
2020 Q2 | -0.04 USD | 1.74% |
2020 FY | - USD | -150.0% |
2020 Q4 | -0.06 USD | -20.32% |
2020 Q3 | -0.05 USD | -28.35% |
2020 Q1 | -0.04 USD | 4.74% |
2019 Q2 | -0.05 USD | 0.0% |
2019 Q4 | -0.04 USD | -90.95% |
2019 Q3 | -0.02 USD | 56.41% |
2019 FY | - USD | -1211.48% |
2019 Q1 | -0.05 USD | 0.0% |
2018 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
ADC Therapeutics SA | -2.94 USD | 88.095% |
Alto Neuroscience, Inc. | -1.35 USD | 74.074% |
Annovis Bio, Inc. | -6.23 USD | 94.382% |
Biohaven Pharmaceutical Holding Company Ltd. | -5.73 USD | 93.892% |
Ginkgo Bioworks Holdings, Inc. | -18.37 USD | 98.095% |
Nuvation Bio Inc. | -0.35 USD | -0.0% |
Arcus Biosciences, Inc. | -4.15 USD | 91.566% |
Theriva Biologics, Inc. | -28.49 USD | 98.771% |
Zymeworks Inc. | -1.72 USD | 79.651% |